Established Companies

From established operations to strategic expansion

Do you need to secure international agreements with strategic partners to achieve your 2030 plan?

Do you require operational support in commercial activities, business development, or open innovation initiatives?

What We Do

Where we add value

Strategic partnership and international expansion support
Open innovation opportunity scouting
Commercial channel optimization
Alignment across BD, marketing, and sales teams
Workflow connectors and process integration
Operational support for growth execution
Our Approach

Established Life Sciences companies often face a different kind of challenge: not how to enter the market, but how to unlock the next phase of growth.

As organizations expand, they frequently need to identify new partnership opportunities, strengthen international business development, activate open innovation initiatives, and improve alignment across commercial, marketing, and business development teams.

BioNext helps established companies turn strategic ambition into coordinated execution by identifying high-value opportunities, supporting strategic agreements, optimizing commercial channels, and implementing more integrated processes and workflow connectors.

The result is stronger alignment, greater visibility, and a more effective platform for sustainable expansion.

Outcome
Stronger alignment, more efficient execution, and new strategic growth opportunities across markets and business units.
Our Methodology

How We Work

01
Analysis
Discovery, Diagnosis & GAP Analysis
02
Planning
Strategic Roadmap & Resource Allocation
03
Execution
Go-to-Market & Operational Deployment
04
Monitoring
Continuous Evaluation & Optimization
Case Studies

Recent Success Stories

Global Expansion

Enabling Investment Access to Global Digital Health Innovation

A leading pharmaceutical group established an international portfolio of digital health companies and connected with global innovation ecosystems, overcoming internal structural limitations to effectively evaluate and secure high-potential investment opportunities.

Read More ↗
Global Expansion

Identifying Strategic Partners for a Novel Therapeutic Program

A mid-sized pharmaceutical company successfully validated global market interest for a novel therapeutic molecule and identified a shortlist of high-potential partners after a strategic screening of over 150 international firms.

Read More ↗
The Team

Our Senior Strategy Team & Advisors

Driven by experienced leaders with decades of impact across global healthcare, business development and strategic advisory.

Foto Ricardo
Managing Partner
Ricardo Acín, EFPA
Investment Strategy
LinkedIn Profile
Foto Daniel
Managing Partner
Daniel González, PhD, MBA
Business Development & Open Innovation
LinkedIn Profile
Foto Andrea
Co-founder
Andrea Maradiaga, MBA
Business Intelligence & Strategy Operations Lead
LinkedIn Profile
Jordi Plaja
Jordi Plaja, PDD
Marketing & Sales Strategy
LinkedIn Profile
Max Brosa
Max Brosa, MBA
Market Access & Health Economics
LinkedIn Profile
Sergio Belza, CFA
Investment Strategy Asia
LinkedIn Profile